Viewing Study NCT06973005


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2025-12-26 @ 2:11 AM
Study NCT ID: NCT06973005
Status: COMPLETED
Last Update Posted: 2025-07-24
First Post: 2025-05-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D7930C00007
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View